RavitBogerMD

Clinical Trials

• A Phase II Randomized and Controlled Investigation of Six Weeks of Oral Valganciclovir Therapy in Infants and Children With Congenital Cytomegalovirus Infection and Hearing Loss Start of enrollment: 2014 Oct 01Boger, R.,DeBiasi, R.,Ampofo, K.K.,Kimberlin, D.,Dennehy, P.,Sanchez, P.J.,Ahmed, A.,Caserta, M.T.,Sood, S.,Storch, G.A.,Whitley, R.J.
• Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection Start of enrollment: 2014 Mar 01Haight, A.,Jacobsohn, D.,Florescu, D.,Yin, D.,Munoz, F.d.,Marty, F.,Maron, G.,Papanicolaou, G.,Mommeja-Marin, H.,Abdel-Azim, H.,Young, J.,Mullane, K.,Yu, L.,Eckrich, M.,Grimley, M.,Agarwal, R.,Goyal, R.,B...
• Evaluation of the Pharmacokinetics and Pharmacodynamics of Ganciclovir in Premature Infants Receiving Treatment for Cytomegalovirus Infection Start of enrollment: 2013 Apr 01Boger, R.,Vanchiere, J.A.,Halasa, N.,Lujan-Zilbermann, J.,Dennehy, P.,Kimberlin, D.,DeBiasi, R.,Michaels, M.G.,Whitley, R.J.,Abzug, M.,Abughali, N.,Romero, J.R.,Ahmed, A.,Sood, S.,Storch, G.A.